22157.jpg
Congenital Adrenal Hyperplasia Landscape Research 2024: Comprehensive Insights About 8+ Pipeline Drugs Featuring Neurocrine Biosciences, Spruce Biosciences, Lundbeck, and HBM Alpha Therapeutics
21 nov. 2024 04h06 HE | Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Congenital Adrenal Hyperplasia - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
PrimaryLogo_Mango-05.png
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
31 oct. 2024 08h00 HE | Mangoceuticals, Inc.
Dallas, Texas, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness...
22157.jpg
Hormone Replacement Therapy (HRT) Market Insights, Competitive Landscape, and Forecast to 2030: Surging Demand for Advanced Drug Delivery Systems Such as Transdermal drugs with Greater Efficacy
22 oct. 2024 10h13 HE | Research and Markets
Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Hormone Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's...
22157.jpg
Hormone Replacement Therapy (HRT) Market to Surpass $30 Billion by 2029 - Oral HRT is the Preferred Choice for Convenience and Compliance
13 juin 2024 04h04 HE | Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Global Hormone Replacement Therapy Market Outlook, 2029" report has been added to ResearchAndMarkets.com's offering. The Global Hormone Replacement...
North American Hormone Replacement Therapy Market
North America Hormone Replacement Therapy (HRT) Market Research 2024: A $6.9 Billion Industry by 2032, Driven by New Treatment Options and Increasing R&D to Enhance Quality and Efficiency
31 mai 2024 04h14 HE | Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "North America Hormone Replacement Therapy Market Report by Product, Route of Administration, Type of Disease, and Country 2024-2032" report has been...
U.S. Sex Reassignment Hormone Therapy Market
United States Sex Reassignment Hormone Therapy Research Report 2024 Featuring Viatris, AbbVie, ASCEND Therapeutics, Pfizer, Eli Lilly and Co, Novartis, Endo International
30 mai 2024 04h13 HE | Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "United States Sex Reassignment Hormone Therapy Market, By Region, Competition, Forecast and Opportunities, 2019-2029F" report has been added to ...
Global Hormone Replacement Market
Global Hormone Replacement Therapy Research Report 2024: A $35+ Billion Market by 2032 - Industry Trends, Share, Growth, Insight, Top Companies
24 mai 2024 07h48 HE | Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Global Hormone Replacement Therapy Market, Size, Forecast 2024-2032, Industry Trends, Share, Growth, Insight, Impact of Inflation, Top Companies...
22157.jpg
Hypoparathyroidism Market Insight, Epidemiology And Market Forecast to 2032
17 mai 2024 04h01 HE | Research and Markets
Dublin, May 17, 2024 (GLOBE NEWSWIRE) -- The "Hypoparathyroidism - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The global...
22157.jpg
5-Alpha Reductase Deficiency Global Market Report 2024: A $1.94 Billion Projected Market in 2028
15 avr. 2024 09h19 HE | Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "5-Alpha Reductase Deficiency Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The 5-alpha reductase deficiency market...
22157.jpg
Synthetic Hormones Market Analysis Report 2023-2033, Featuring Profiles of Eli Lilly, Pfizer, Ferring, Merck, Novo Nordisk, Bayer, Novartis and More
27 nov. 2023 04h28 HE | Research and Markets
Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The "Global Synthetic Hormones Market: Focus on Product Type, Application, Route of Administration, End User, Region, and Competitive Landscape - Analysis...